Sector: Biological Products, (No Diagnostic Substances)Industry: BiotechnologyCountry: USExchange: Nasdaq
DilutionScan read 52 of Artiva Biotherapeutics, Inc.'s SEC filings and found 1 warrant series, 2 ATM programs, 2 shelf registrations and 1 completed offering on file for ARTV. The latest dilution event on file is a registration statement on Aug 14, 2026. Analysis updated Oct 31, 2026.
DilutionScan ProEvery instrument in full ยท $59/mo
Covered companies in Biotechnology. All tickers A to Z
PLXProtalix BioTherapeutics, Inc.
ACIUAC Immune SA
IKTInhibikase Therapeutics, Inc.
AKBAAkebia Therapeutics, Inc.
ELDNEledon Pharmaceuticals, Inc.
ADCTADC Therapeutics SA
PYXSPyxis Oncology, Inc.
RNACCartesian Therapeutics, Inc.
DTILPrecision BioSciences, Inc.
PALIPalisade Bio, Inc.
SLGLSol-Gel Technologies Ltd. Ordinary Shares
KRROKorro Bio, Inc.
CGENCompugen Ltd
PRQRProQR Therapeutics N.V. Ordinary Shares
BBOTBridgeBio Oncology Therapeutics Inc.